First Report of Salmonella Serovar Typhimurium and Monophasic Typhimurium Clinical Isolates Harboring mcr-9 in Portugal
DOI:
https://doi.org/10.20344/amp.20111Keywords:
Colistin/pharmacology, Drug Resistance, Bacterial, Microbial Sensitivity Tests, Salmonella typhimurium/geneticsAbstract
N/a.
Downloads
References
Chatzidimitriou M, Kavvada A, Kavvadas D, Kyriazidi MA, Meletis G, Chatzopoulou F, et al. mcr genes conferring colistin resistance in enterobacterales; a five year overview. Acta Med Acad. 2021;50:365-71. DOI: https://doi.org/10.5644/ama2006-124.355
Leite EL, Araújo WJ, Vieira TR, Zenato KS, Vasconcelos PC, Cibulski S, et al. First reported genome of an mcr-9-mediated colistin-resistant salmonella typhimurium isolate from Brazilian livestock. J Glob Antimicro Resist. 2020;23:394-97. DOI: https://doi.org/10.1016/j.jgar.2020.09.012
Bertelloni F, Cagnoli G, Turchi B, Ebani VV. Low level of colistin resistance and mcr genes presence in salmonella spp.: evaluation of isolates collected between 2000 and 2020 from animals and environment. Antibiotics. 2022;11:272-80. DOI: https://doi.org/10.3390/antibiotics11020272
Kieffer N, Royer G, Decousser JW, Bourrel AS, Palmieri M, Ortiz De La Rosa JM, et al. mcr-9, an inducible gene encoding an acquired phosphoethanolamine transferase in escherichia coli, and its origin. Antimicrob Agents Chemother. 2019;63:e00965-19. DOI: https://doi.org/10.1128/AAC.01866-19
Haenni M, Métayer V, Jarry R, Drapeau A, Puech MP, Madec JY, et al. Wide spread of blactx–m–9/mcr-9 inchi2/st1 plasmids and ctx-m-9-producing escherichia coli and enterobacter cloacae in rescued wild animals. Front Microbiol. 2020;11:1-8. DOI: https://doi.org/10.3389/fmicb.2020.601317
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Acta Médica Portuguesa
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.
It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.
Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.
After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.